Phase II study of SB 9200 in patients with Hepatitis B Virus (HBV) Infection

Trial Profile

Phase II study of SB 9200 in patients with Hepatitis B Virus (HBV) Infection

Planning
Phase of Trial: Phase II

Latest Information Update: 14 Apr 2016

At a glance

  • Drugs Inarigivir soproxil (Primary)
  • Indications Hepatitis B
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Apr 2016 Planned initiation date changed from 1 Dec 2015 to 1 May 2016, as reported in a Spring Bank Pharmaceuticals media release.
    • 29 Apr 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top